Matthew Herder

Matthew Herder is an Assistant Professor at Dalhousie University, with cross-appointments to the Faculty of Medicine and Schulich School of Law. He serves as Director of the Health Law Institute and specializes in biomedical innovation policy, analyzing legal frameworks impacting healthcare technologies. Herder holds a Master of Science in Law from Stanford University, law degrees from Dalhousie, and a science degree from Memorial University.

Education:

• Master of the Science of Law (Stanford Law School)
• Law Degrees (Dalhousie University)
• Bachelor's in Science (Memorial University)

Professional Background:

• Former Visiting Professor of Law at Loyola University Chicago
• Kauffman Fellow at NYU School of Law
• Policy Consultant to Health Canada
• Clerk at the Federal Court of Canada

Research Focus: Herder examines how laws and policies shape biomedical innovation, including drug regulation, clinical trial transparency, and public health governance. His work emphasizes equitable access to healthcare technologies and systemic reforms in regulatory agencies like the FDA and Health Canada.

Grants & Awards: Funded by CIHR, SSHRC, Genome Canada, and the Royal Society of Canada. His research has informed parliamentary committees and international bodies like the OECD.

Key Contributions: Advocacy for transparency in clinical trials, critiques of accelerated drug approvals, and policy recommendations to address opioid-related harms and pandemic preparedness. His interdisciplinary approach bridges legal, scientific, and public health perspectives.